Webinars » Unlocking CRISPR: Advances in Base Editing, Prime Editing & Future Applications | GenScript

Unlocking CRISPR: Advances in Base Editing & Prime Editing and Future Applications

In the rapidly evolving field of gene editing, CRISPR technology has emerged as a revolutionary tool, enabling precise and efficient genome modifications. While the CRISPR-Cas9 system has garnered widespread attention for its ability to create double-strand breaks at specific DNA sites, the development of newer CRISPR-based tools, such as Base Editors (BEs) and Prime Editors (PEs), has significantly expanded the scope of genetic engineering. These advanced tools offer unparalleled precision, minimizing off-target effects and opening new avenues for research and therapeutic applications.

This webinar will explore the mechanisms behind these cutting-edge tools, recent breakthroughs, and their transformative potential in genetic research and medicine.

In this webinar, you will learn about:

The mechanisms behind Base Editing and Prime Editing technologies.

The latest research advancements and breakthroughs in CRISPR-based gene editing.

Potential therapeutic applications and their future impact on medicine.

GenScript's new services related to Base Editor and Prime Editor proteins, including case studies of Cas proteins.

GenScript's new Cas protein expression service, with Base Editor and Prime Editor case studies.

In this webinar, you will learn

Webinar Details

  • Date: October 30th, 2024
  • Time: 10:00 am EDT (NA) / 3:00pm BST (UK) / 4:00pm CEST (EU-Central)
  • Speaker:
Dr. Bon-Kyoung Koo Dr. Jiabao Lv

Sr. Protein Scientist - GenScript Biotech

Dr. Jiabao Lv is a dedicated Senior Protein Scientist at GenScript, where she has been actively involved in the research and development of Base Editors (BE) and Prime Editors (PE) over the past two years. She earned her Ph.D. in Biochemistry and Molecular Biology from Jilin University in 2022 and gained additional research experience as a visiting Ph.D. student at Aarhus University.
Dr. Lv’s work at GenScript focuses on developing enzyme product and activity assay, with a particular emphasis on CRISPR/Cas nucleases and molecular enzymes. In addition to her work at GenScript, Dr. Lv has developed a solid foundation in enzyme activity assays, crucial for advancing molecular biology. She has authored five SCI papers in respected journals, covering areas such as enzyme immobilization, semi-rational enzyme design, and the biosynthesis of prebiotics. Her research reflects a thoughtful and methodical approach to protein science,

Speaker-related Webinars

Latest Webinars

Find More Protein Categories »

Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript

Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript

AI-based Antibody Therapeutics Developability Assessment and Its Engineering

AI-based Antibody Therapeutics Developability Assessment and Its Engineering

Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers

Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers